PARIS - BioAlliance Pharma SA launched an IPO on Eurolist Compartment C of the Euronext stock exchange in Paris with the aim of raising €29.5 to €33.8 million and, in the words of its chairman and co-founder, Dominique Costantini, of "transmuting from a drug discovery company into a profitable pharmaceutical company." (BioWorld International)